Turn Therapeutics Inc. (TTRX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Turn Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$11.12
+6.72% today
Market cap
$318M
Overall quality
—
Kronos AI 30-day
+2.7%
4 of 8 simulated paths end higher
Turn Therapeutics Inc. (TTRX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $318M. It trades at $11.12, up 6.72% today. 3 analysts' average target of $16.67 implies +49.9% from today's price. Kronos AI's 30-day forecast is +2.7% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $16.67 |
| Low – high | $10.00 – $24.00 |
| Analysts | 3 |
| Upside to average | +49.9% |
Kronos AI 30-day forecast
| Expected close | $10.70 (+2.7%) |
| Likely range | −43.6% … +8.3% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.